By Amina Niasse and Mariam Sunny NEW YORK (Reuters) -CVS Health projected double-digit earnings growth for 2026 on Wednesday after raising its 2025 profit forecast for the third time, showing steady progress in its turnaround efforts. CVS said it foresees mid-teens percentage profit growth versus 2025. It said it will announce a more detailed outlook …
CVS Health forecasts double-digit earnings growth for 2026 Read More »
-Ford is recalling nearly 175,000 vehicles in the U.S. as their moonroof wind deflectors could detach, the U.S. National Highway Traffic Safety Administration said on Wednesday. The recall covers Ford Expedition and Lincoln Navigator SUVs, and F-series pickup trucks, NHTSA said. Dealers will inspect and repair the wind deflectors free of charge, the agency added. …
Ford recalls nearly 175,000 vehicles in US for moonroof defect, NHTSA says Read More »
By Michael S. Derby NEW YORK (Reuters) -The Federal Reserve’s Standing Repo Facility on Wednesday recorded the highest level of usage since its launch in 2021, as central bankers are widely expected to announce an end to their balance sheet drawdown. Eligible financial firms took slightly over $10 billion in loans from the facility, widely …
Fed’s Standing Repo Facility hits record high as policy meeting outcome looms Read More »
By Tommy Reggiori Wilkes LONDON (Reuters) -Blackstone Apollo and Ares had no exposure to U.S. companies First Brands and Tricolor at the time of their bankruptcies, executives said on Wednesday, arguing that the private credit industry had been unfairly linked to the collapses. The failure of auto parts supplier First Brands and car dealership Tricolor …
Private credit bosses hit back at ‘misinformation’ over First Brands collapse Read More »
By Yousef Saba and Federico Maccioni RIYADH (Reuters) -Saudi Arabia is preparing to shift its $925 billion sovereign wealth fund away from a focus on real estate gigaprojects that have dominated its development goals for the last decade, a source with direct knowledge of the plans told Reuters. Crown Prince Mohammed bin Salman, the de …
(Reuters) -Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer’s pharmacies across the United States at direct-to-consumer prices. This marks the first time the drugmaker has provided a retail pick-up option to customers who use the LillyDirect website to order Zepbound, it said. Self-paying customers …
Lilly, Walmart launch discount retail option for weight-loss drug Zepbound Read More »
By Neil J Kanatt (Reuters) -Kraft Heinz lowered its annual sales and profit forecasts on Wednesday, signaling that budget-conscious consumers continue to push back against pricier snacks and pantry condiments. The results, which sent shares down about 3%, come as the packaged goods maker presses ahead with plans to separate into two companies, with one …
Kraft Heinz trims annual sales, profit forecasts as demand remains stressed Read More »
(Refiles to restore garbled words in final paragraph) By Daniel Leussink and Maki Shiraki TOKYO (Reuters) -Japan’s Toyota Motor did not explicitly promise a new $10 billion investment in the United States, a senior executive said on Wednesday, a day after President Donald Trump mentioned a potential investment of that size. Speaking during his visit …
Toyota says it did not explicitly promise Trump new $10 billion investment in US Read More »
(Reuters) -Artificial intelligence server maker Super Micro Computer on Wednesday said it has created a subsidiary catering to U.S. federal agencies, amid a drive to increase efficiency in the government. Shares of the company were up around 3%. The White House in April had ordered federal agencies to name chief AI officers and develop strategies …
Super Micro’s new subsidiary to offer AI server support to US government Read More »
(Reuters) -Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, as the drugmaker looks to increase its U.S. production capacity to hedge against potential tariffs. The revamped facility in Carolina, Puerto Rico will help manufacture Lilly’s weight-loss pill, orforglipron, for which the company expects …
Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push Read More »
